Lv2
120 积分 2025-06-22 加入
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
3天前
待确认
Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment
1个月前
已完结
Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment
1个月前
已完结
Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management
1个月前
已完结
Implementing electronic health record–integrated screening of patient‐reported symptoms and supportive care needs in a comprehensive cancer center
1个月前
已完结
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401
1个月前
已完结
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer
3个月前
已完结
Clinical outcomes and predictive factors of immunotherapy efficacy in non-small-cell lung cancer brain metastases: a comparative study
5个月前
已完结
Intravesical Administration of Durvalumab for High-risk Non–muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group
7个月前
已完结
皖公网安备34019202002308
